Nicotine effects on anterior cingulate cortex in schizophrenia and healthy smokers as revealed by EEG-informed fMRI

Psychiatry Research - Neuroimaging

Volumn 204, Issue 2-3, 2012, Pages 168-177

  Mobascher, Arian ^a,b   Warbrick, Tracy ^a,c   Brinkmeyer, Juergen ^a,c   Musso, Francesco ^c   Stoecker, Tony ^a   Jon Shah, N ^a   Winterer, Georg ^a,d  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anterior cingulate cortex; Electroencephalography; Functional magnetic resonance imaging; Nicotine; Schizophrenia

Indexed keywords

NICOTINE; PLACEBO;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; TASK PERFORMANCE; VISUAL STIMULATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; OXYGEN; SCHIZOPHRENIA; SMOKING; YOUNG ADULT;

EID: 84872394384     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.09.005     Document Type: Article

References (73)

1. Allen P., Josephs O., Turner R. A method for removing imaging artifact from continuous EEG recorded during functional MRI. NeuroImage 2000, 12:230-239.
2. Allen P., Polizzi G., Krakow K., Fish D.R., Lemieux L. Identification of EEG Events in the MR scanner: The problem of pulse artifact and a method for its subtraction. NeuroImage 1998, 8:229-239.
3. Aubin H.J., Rollema H., Svensson T.H., Winterer G. Smoking, quitting, and psychiatric disease: a review. Neuroscience and Biobehavioural Reviews 2012, 36:271-284.
4. Barr R.S., Culhane M.A., Jubelt L.E., Mufti R.S., Dyer M.A., Weiss A.P., Deckersbach T., Kelly J.F., Freudenreich O., Goff D.C., Evins A.E. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:480-490.
5. Baudena P., Halgren E., Heit G., Clarke J.M. Intracerebral potentials to rare target and distractor auditory and visual stimuli. III. Frontal cortex. Electroencephalography and Clinical Neurophysiology 1995, 94:251-264.
6. Beaver J.D., Long C.J., Cole D.M., Durcan M.J., Bannon L.C., Mishra R.G., Matthews P.M. The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous EEG/fMRI. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2011, 36:1792-1900.
7. Behrens, T., Woolrich, M.W., Smith, S., 2003. Multi-testing using a fully subject null hypothesis Bayesian framework: theory. In: Proceedings of the Human Brain Mapping Meeting, New York City.
8. Bénar C.G., Schön D., Grimault S., Nazarian B., Burle B., Roth M., Badier J.M., Marquis P., Liegeois-Chauvel C., Anton J.L. Single-trial analysis of oddball event-related potentials in simultaneous EEG-fMRI. Human Brain Mapping 2007, 28:602-613.
9. Benowitz N.L. Nicotine addiction. New England Journal of Medicine 2010, 362:2295-2303.
10. Bierut L.J., Stitzel J.A., Wang J.C., Hinrichs A.L., Grucza R.A., Xuei X., Saccone N.L., Saccone S.F., Bertelsen S., Fox L., Horton W.J., Breslau N., Budde J., Cloninger C.R., Dick D.M., Foroud T., Hatsukami D., Hesselbrock V., Johnson E.O., Kramer J., Kuperman S., Madden P.A., Mayo K., Nurnberger J., Pomerleau O., Porjesz B., Reyes O., Schuckit M., Swan G., Tischfield J.A., Edenberg H.J., Rice J.P., Goate A.M. Variants in nicotinic receptors and risk for nicotine dependence. American Journal of Psychiatry 2008, 165:1163-1171.
11. Biessmann F., Plis S., Meinecke F.C., Eichele T., Müller K.R. Analysis of multimodal neuroimaging data. IEEE Reviews in Biomedical Engineering 2011, 4:26-58.
12. Bowie C.R., Reichenberg A., Patterson T.L., Heaton R.K., Harvey P.D. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. American Journal of Psychiatry 2006, 163:418-425.
13. Brinkmeyer J., Mobascher A., Musso F., Schmitz M., Wagner M., Frommann I., Gründer G., Spreckelmeyer K.N., Wienker T., Díaz-Lacava A., Holler D., Dahmen N., Thuerauf N., Clepce M., Kiefer F., de Millas W., Gallinat J., Winterer G. P50 sensory gating and smoking in the general population. Addiction Biology 2011, 16:485-498.
14. Brunzell D.H., McIntosh J.M. Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2012, 37:1134-1143.
15. Debener S., Ullsperger M., Siegel M., Fiehler K., von Cramon D.Y., Engel A.K. Trial-by-trial coupling of concurrent electroencephalogram and functional magnetic resonance imaging identifies the dynamics of performance monitoring. Journal of Neuroscience 2005, 25:11730-11737.
16. Eichele T., Specht K., Moosmann M., Jongsma M.L., Quiroga R.Q., Nordby H., Hugdahl K. Assessing the spatiotemporal evolution of neuronal activation with single trial event-related potentials and functional MRI. Proceedings of the National Academy of Sciences USA 2005, 102:17798-17803.
17. Ettinger U., Williams S.C., Patel D., Michel T.M., Nwaigwe A., Caceres A., Mehta M.A., Anilkumar A.P., Kumari V. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity. NeuroImage 2009, 45:549-561.
18. First M.B., Spitzer R.L., Giddon M., Williams J.B. The Structured Clinical Interview for DCM-IV Axis I Disorders Research Version (SCID-1) 1995, American Psychiatric Press, New York.
19. Forman S.D., Cohen J.D., Fitzgerald M., Eddy W.F., Mintun M.A., Noll D.C. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magnetic Resonance in Medicine 1995, 33:636-647.
20. Fornito A., Yücel M., Dean B., Wood S.J., Pantelis C. Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophrenia Bulletin 2009, 35:973-993.
21. Friston K.J., Worsley K.J., Frackowiak R.S.J., Mazziotta J.C., Evans A.C. Assessing the significance of focal activations using their spatial extent. Human Brain Mapping 1994, 1:214-220.
22. Gallinat J., Mulert C., Bajbouj M., Herrmann W.M., Schunter J., Senkowski D., Moukhtieva R., Kronfeldt D., Winterer G. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. NeuroImage 2002, 17:110-127.
23. Gulick D., Gould T.J. Nicotine acts in the anterior cingulate, but not dorsal or ventral hippocampus, to reverse ethanol-induced learning impairments in the plus-maze discriminative avoidance task. Addiction Biology 2011, 16:176-188.
24. Gur R.E., Turetsky B.I., Loughead J., Snyder W., Kohler C., Elliott M., Pratiwadi R., Ragland J.D., Bilker W.B., Siegel S.J., Kanes S.J., Arnold S.E., Gur R.C. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. American Journal of Psychiatry 2007, 164:442-449.
25. Hahn B., Ross T.J., Yang Y., Kim I., Huestis M.A., Stein E.A. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. Journal of Neuroscience 2007, 27:3477-3489.
26. Halgren E., Baudena P., Clarke J.M., Heit G. Intracerebral potentials to rare target and distractor auditory and visual stimuli. I. Superior temporal plane and parietal lobe. Electroencephalography and Clinical Neurophysiology 1995, 94:191-220.
27. Halgren E., Baudena P., Clarke J.M., Heit G. Intracerebral potentials to rare target and distractor auditory and visual stimuli. II. Medial, lateral and posterior temporal lobe. Electroencephalography and Clinical Neurophysiology 1995, 94:229-250.
28. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction 1991, 86:1119-11127.
29. Hong L.E., Schroeder M., Ross T.J., Buchholz B., Salmeron B.J., Wonodi I., Thaker G.K., Stein E.A. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophrenia Bulletin 2011, 37:416-425.
30. Hong L.E., Hodgkinson C.A., Yang Y., Sampath H., Ross T.J., Buchholz B., Salmeron B.J., Srivastava V., Thaker G.K., Goldman D., Stein E.A. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proceedings of the National Academy of Sciences USA 2010, 107:13509-13514.
31. Hong L.E., Thaker G.K., McMahon R.P., Summerfelt A., Rachbeisel J., Fuller R.L., Wonodi I., Buchanan R.W., Myers C., Heishman S.J., Yang J., Nye A. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Archives of General Psychiatry 2011, 68:1195-1206.
32. Hurt R.D., Offord K.P., Croghan I.T., Croghan G.A., Gomez-Dahl L.C., Wolter T.D., Dale L.C., Moyer T.P. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology 1998, 140:98-104.
33. Huster R.J., Debener S., Eichele T., Herrmann C. Methods for simultaneous EEG-fMRI: an introductory review. Journal of Neuroscience 2012, 32:6053-6060.
34. Iannetti G.D., Wise R.G. BOLD functional MRI in disease and pharmacological studies: room for improvement?. Magnetic Resonance Imaging 2007, 25:978-988.
35. Jacobsen L.K., D'Souza D.C., Mencl W.E., Pugh K.R., Skudlarski P., Krystal J.H. Nicotine effects on brain function and functional connectivity in schizophrenia. Biological Psychiatry 2004, 55:850-858.
36. Jenkinson M., Bannister P., Brady J., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 2002, 17:825-841.
37. Jubelt L.E., Barr R.S., Goff D.C., Logvinenko T., Weiss A.P., Evins A.E. Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology 2008, 199:89-98.
38. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
39. Keefe, R.S., Buchanan, R.W., Marder, S.R., Schooler, N.R., Dugar, A., Zivkov, M., Stewart, M. Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? Schizophrenia Bulletin, in press. http://dx.doi.org/10.1093/schbul/sbr153.
40. Kiehl K.A., Stevens M.C., Celone K., Kurtz M., Krystal J.H. Abnormal hemodynamics in schizophrenia during an auditory oddball task. Biological Psychiatry 2005, 57:1029-1040.
41. Lawrence N.S., Rose T.J., Stein E.A. Cognitive mechanism of nicotine on visual attention. Neuron 2002, 36:539-548.
42. Leonard S., Freedman R. Genetics of chromosome 15q13-q14 in schizophrenia. Biological Psychiatry 2006, 60:115-122.
43. Lindenberg A., Brinkmeyer J., Dahmen N., Gallinat J., de Millas W., Mobascher A., Wagner M., Schulze-Rauschenbach S., Gründer G., Spreckelmeyer K.N., Clepce M., Thürauf N., von der Goltz C., Kiefer F., Steffens M., Holler D., Díaz-Lacava A., Wienker T., Winterer G. The German multicenter study on smoking-related behavior: description of a population-based case-control study. Addiction Biology 2011, 16:638-653.
44. Loughead J., Ray R., Wileyto E.P., Ruparel K., Sanborn P., Siegel S., Gur R.C., Lerman C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological Psychiatry 2010, 67:715-721.
45. Mathalon D.H., Ford J.M., Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biological Psychiatry 2000, 47:434-449.
46. McClernon F.J. Neuroimaging of nicotine dependence. key findings and application to the study of smoking-mental illness comorbidity. Journal of Dual Diagnosis 2009, 5:168-178.
47. Merz J., Lehrl S., Galster V., Erzigkeit H. The multiple selection vocabulary test (MSVT-B)-an accelerated intelligence test. Psychiatry, Neurology and Medical Psychology 1975, 27:423-428.
48. Mobascher A., Brinkmeyer J., Warbrick T., Musso F., Wittsack H.J., Saleh A., Schnitzler A., Winterer G. Laser-evoked potential P2 single-trial amplitudes covary with the fMRI BOLD response in the medial pain system and interconnected subcortical structures. NeuroImage 2009, 45:917-926.
49. Mobascher A., Brinkmeyer J., Warbrick T., Wels C., Wagner M., Gründer G., Spreckelmeyer K.N., Wienker T., Diaz Lacava A., Dahmen N., Böttcher M., Thuerauf N., Clepce M., Kiefer F., De Millas W., Gallinat J., Winterer G. The P300 event-related potential and smoking-a population-based case-control study. International Journal of Psychophysiology 2010, 77:166-175.
50. Mulert C., Gallinat J., Pascual-Marqui R., Dorn H., Frick K., Schlattmann P., Mientus S., Herrmann W.M., Winterer G. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. NeuroImage 2001, 13:589-600.
51. Mulert C., Seifert C., Leicht G., Kirsch V., Ertl M., Karch S., Moosmann M., Lutz J., Möller H.J., Hegerl U., Pogarell O., Jäger L. Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making. NeuroImage 2008, 42:158-168.
52. Musso F., Brinkmeyer J., Ecker D., London M.K., Thieme G., Warbrick T., Wittsack H.J., Saleh A., Greb W., de Boer P., Winterer G. Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task. NeuroImage 2011, 58:508-525.
53. Neuhaus A.H., Koehler S., Opgen-Rhein C., Urbanek C., Hahn E., Dettling M. Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study. Journal of Psychiatric Research 2007, 41:635-644.
54. Oostenveld R., Praamstra P. The five percent electrode system for highresolution EEG and ERP measurement. Clinical Neurophysiology 2001, 112:713-719.
55. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. International Journal of Psychophysiology 2006, 60:172-175.
56. Postma P., Gray J.A., Sharma T., Geyer M., Mehrotra R., Das M., Zachariah E., Hines M., Williams S.C., Kumari V. A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology 2006, 184:589-599.
57. Preuss U.W., Zetzsche T., Pogarell O., Mulert C., Frodl T., Müller D., Schmidt G., Born C., Reiser M., Möller H.-J., Hegerl U., Meisenzahl E.M. Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms. Psychiatry Research: Neuroimaging 2010, 183:133-139.
58. Pritchard W., Sokhadze E., Houlihan M. Effects of nicotine and smoking on event-related potentials: a review. Nicotine and Tobacco Research 2004, 6:961-984.
59. Rorden C., Karnath H.O., Bonilha L. Improving lesion-symptom mapping. Journal of Cognitive Neuroscience 2007, 19:1081-1088.
60. Tanabe J., Tregellas J.R., Martin L.F., Freedman R. Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia. Biological Psychiatry 2006, 59:754-761.
61. Thiel C.M., Zilles K., Fink G.R. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2005, 30:810-820.
62. Tiffany S.T., Drobes D.J. The development and initial validation of a questionnaire on smoking urges. British Journal of Addiction 1991, 86:1467-1476.
63. Tregellas J.R., Olincy A., Johnson L., Tanabe J., Shatti S., Martin L.F., Singel D., Du Y.P., Soti F., Kem W.R., Freedman R. Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2010, 35:938-942.
64. Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophrenia Bulletin 2007, 33:69-94.
65. Wallace T.L., Porter R.H.P. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochemical Pharmacology 2011, 82:891-903.
66. Warbrick T., Mobascher A., Brinkmeyer J., Musso F., Stoecker T., Shah N.J., Fink G.R., Winterer G. Nicotine effects on brain function during a visual oddball task: a comparison between conventional and EEG-informed fMRI analysis. Journal of Cognitive Neuroscience 2012, 24:1682-1694.
67. Warbrick T., Mobascher A., Brinkmeyer J., Musso F., Stoecker T., Shah N.J., Vossel S., Winterer G. Direction and magnitude of nicotine effects on the fMRI BOLD response are related to nicotine effects on behavioural performance. Psychopharmacology 2011, 215:333-344.
68. Warbrick T., Mobascher A., Brinkmeyer J., Musso F., Richter N., Stoecker T., Fink G.R., Shah N.J., Winterer G. Single-trial P3 amplitude and latency informed event-related fMRI models yield different BOLD response patterns to a target detection task. NeuroImage 2009, 47:1532-1544.
69. Winterer G. Why do patients with schizophrenia smoke?. Current Opinion in Psychiatry 2010, 23:112-119.
70. Winterer G., Mulert C., Mientus S., Gallinat J., Schlattmann P., Dorn H., Herrmann W.M. P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topography 2001, 13:299-313.
71. Winterer G., Musso F., Konrad A., Vucurevic G., Stoeter P., Sander T., Gallinat J. Association of attentional network function with exon 5 variations of the CHRNA4 gene. Human Molecular Genetics 2007, 16:2165-2174.
72. Woolrich M.W., Ripley B.D., Brady M., Smith S.M. Temporal autocorrelation in univariate linear modelling of fMRI data. NeuroImage 2001, 14:1370-1386.
73. Worsley K.J., Evans A.C., Marrett S., Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. Journal of Cerebral Blood Flow and Metabolism 1992, 12:900-918.